Financial Data Sheet
9 May 2017 – Interim Management Statement
Please go to Events & Presentations, if you wish to see the latest IR presentation
Download and browse reports, presentations and documents within the areas Annual General Meeting, Investor Relations, Responsibility, Corporate Governance and Business policies.
2016: DKK 12,002 million
2015: DKK 10,665 million
2016: DKK 2,130 million
2015: DKK 1,902 million
latest annual report
The William Demant Group is one of the world’s leading hearing healthcare companies. We are in the business of making a life-changing difference for millions of people across the world.
We are the only company in the world that covers all the four business activities of the hearing healthcare area, i.e. traditional hearing instruments, hearing implants, diagnostic instruments as well as personal communication.
With our approach to hearing healthcare and our complete product range, we are fully equipped to help people with various kinds of hearing loss connect with the world and live their lives to the fullest.
The William Demant Group is one of the world’s leading hearing healthcare companies making a life-changing difference to millions of people all over the world.
Find presentations from events such as Interim Reports and Information, Capital Markets Days and Annual General Meetings.
With a unique position in the hearing healthcare market, based on true innovation and an efficient global set-up, we are equipped to help millions of people.
Listed on Nasdaq Copenhagen as part of the OMXC20 index portfolio consisting of the 20 most traded shares of the 25 largest shares in terms of free floated market capitalisation, William Demant is a leading global company that develops, manufactures and sells hearing instruments, hearing implants, diagnostic instruments and personal communication devices. William Demant Invest, wholly owned by the Oticon Foundation, holds the majority shares in William Demant Holding, the company behind the commercial successes of such world-renowned brands as Oticon, Bernafon, Sonic, Oticon Medical, Maico, Interacoustics, Grason-Stadler and Sennheiser Communications.
The Group operates in a global market with companies in more than 30 countries, a total staff exceeding 12,000 and generates annual revenues of more than DKK 12 billion. Our products are sold in more than 130 countries.